Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS:
6 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS
6.1 EUROPEAN UNION REGULATORY SCENARIO
6.2 U.S. REGULATORY SCENARIO
6.3 JAPAN REGULATORY SCENARIO
6.4 CHINA REGULATORY SCENARIO
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
7.1.3 GROWING DEMAND FOR CHIMERIC GENES
7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
7.2 RESTRAINTS
7.2.1 HIGH COST OF TRANSFECTION PRODUCTS
7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
7.3 OPPORTUNITIES
7.3.1 EXPLORATION OF EMERGING MARKET
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 SURGING LEVEL OF INVESTMENT
7.4 CHALLENGES
7.4.1 LONG APPROVAL PROCEDURE
7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION
7.4.3 LACK OF TRAINED PROFESSIONALS
8 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS
8.1 OVERVIEW
8.2 REAGENTS & KITS
8.3 INSTRUMENTS
9 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE
9.1 OVERVIEW
9.2 RESEARCH
9.3 PRECLINICAL
9.4 CLINICAL PHASES
9.5 COMMERCIAL
10 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE
10.1 OVERVIEW
10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT
10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT
11 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS
11.1 OVERVIEW
11.2 NON-VIRAL METHODS
11.3 VIRAL METHODS
12 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE
12.1 OVERVIEW
12.2 PLASMID DNA
12.3 SMALL INTERFERING RNA (SIRNA)
12.4 PROTEINS
12.5 DNA OLIGONUCLEOTIDES
12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
12.7 OTHERS
13 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM
13.1 OVERVIEW
13.2 MAMMALIAN CELLS
13.3 PLANTS
13.4 FUNGI
13.5 VIRUS
13.6 BACTERIA
14 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 IN VITRO APPLICATION
14.2.1 IN VIVO APPLICATION
14.2.2 BIOPRODUCTION
14.2.3 OTHERS
14.2.4 SYNTHETIC BIOLOGY
14.2.5 AGRICULTURE
14.2.6 OTHERS
15 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 BIOPHARMA
15.3 CROS
15.4 CMOS/CDMOS
15.5 ACADEMIA
15.6 HOSPITALS
15.7 CLINICAL LABS
15.8 OTHERS
16 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION
17.1 NORTH AMERICA
17.1.1 U.S.
17.1.2 CANADA
17.1.3 MEXICO
18 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 THERMO FISHER SCIENTIFIC INC.
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENT
20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 PROMEGA CORPORATION
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 TAKARA BIO INC.
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENT
20.5 BIO-RAD LABORATORIES, INC.
20.5.1 COMPANY SNAPSHOT
20.5.2 REVENUE ANANLYSIS
20.5.3 COMPANY SHARE ANALYSIS
20.5.4 PRODUCT PORTFOLIO
20.5.5 RECENT DEVELOPMENT
20.6 ALTOGEN BIOSYSTEMS
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
20.8.1 COMPANY SNAPSHOT
20.8.2 REVENUE ANALYSIS
20.8.3 PRODUCT PORTFOLIO
20.8.4 RECENT DEVELOPMENT
20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 CYTIVA
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
20.11.1 COMPANY SNAPSHOT
20.11.2 REVENUE ANANLYSIS
20.11.3 PRODUCT PORTFOLIO
20.11.4 RECENT DEVELOPMENT
20.12 GENLANTIS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 GENO TECHNOLOGY INC., USA
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENT
20.14 GINKGO BIOWORKS
20.14.1 COMPANY SNAPSHOT
20.14.2 PRODUCT PORTFOLIO
20.14.3 RECENT DEVELOPMENTS
20.15 LONZA
20.15.1 COMPANY SNAPSHOT
20.15.2 REVENUE ANANLYSIS
20.15.3 PRODUCT PORTFOLIO
20.15.4 RECENT DEVELOPMENT
20.16 MAXCYTE, INC.
20.16.1 COMPANY SNAPSHOT
20.16.2 REVENUE ANALYSIS
20.16.3 PRODUCT PORTFOLIO
20.16.4 RECENT DEVELOPMENT
20.17 MERCK KGAA
20.17.1 COMPANY SNAPSHOT
20.17.2 REVENUE ANALYSIS
20.17.3 PRODUCT PORTFOLIO
20.17.4 RECENT DEVELOPMENT
20.18 MIRUS BIO LLC.
20.18.1 COMPANY SNAPSHOT
20.18.2 PRODUCT PORTFOLIO
20.18.3 RECENT DEVELOPMENT
20.19 ORIGENE TECHNOLOGIES, INC.
20.19.1 COMPANY SNAPSHOT
20.19.2 PRODUCT PORTFOLIO
20.19.3 RECENT DEVELOPMENT
20.2 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
20.20.1 COMPANY SNAPSHOT
20.20.2 REVENUE ANALYSIS
20.20.3 PRODUCT PORTFOLIO
20.20.4 RECENT DEVELOPMENT
20.21 POLYPLUS TRANSFECTION
20.21.1 COMPANY SNAPSHOT
20.21.2 PRODUCT PORTFOLIO
20.21.3 RECENT DEVELOPMENT
20.22 R&D SYSTEMS, INC.
20.22.1 COMPANY SNAPSHOT
20.22.2 PRODUCT PORTFOLIO
20.22.3 RECENT DEVELOPMENT
20.23 SBS GENETECH
20.23.1 COMPANY SNAPSHOT
20.23.2 PRODUCT PORTFOLIO
20.23.3 RECENT DEVELOPMENT
20.24 SIGNAGEN LABORATORIES
20.24.1 COMPANY SNAPSHOT
20.24.2 PRODUCT PORTFOLIO
20.24.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND)
TABLE 2 NORTH AMERICA REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 3 NORTH AMERICA INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND)
TABLE 5 NORTH AMERICA RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 NORTH AMERICA PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 NORTH AMERICA CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 NORTH AMERICA COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 10 NORTH AMERICA TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 NORTH AMERICA STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND)
TABLE 13 NORTH AMERICA NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 NORTH AMERICA VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND)
TABLE 16 NORTH AMERICA PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 NORTH AMERICA SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 18 NORTH AMERICA PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 NORTH AMERICA DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 NORTH AMERICA RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 NORTH AMERICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND)
TABLE 23 NORTH AMERICA MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 NORTH AMERICA PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 NORTH AMERICA FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 NORTH AMERICA VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 NORTH AMERICA BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 29 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 30 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 NORTH AMERICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 NORTH AMERICA APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND)
TABLE 34 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 35 NORTH AMERICA BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 36 NORTH AMERICA CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 NORTH AMERICA CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 NORTH AMERICA ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 NORTH AMERICA HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 40 NORTH AMERICA CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 41 NORTH AMERICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 42 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 43 NORTH AMERICA DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 44 NORTH AMERICA RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 45 NORTH AMERICA OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)
List of Figure
FIGURE 1 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030
FIGURE 13 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030
FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET
FIGURE 16 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023
FIGURE 17 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND)
FIGURE 18 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030)
FIGURE 19 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 20 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023
FIGURE 21 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND)
FIGURE 22 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030)
FIGURE 23 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023
FIGURE 25 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND)
FIGURE 26 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 27 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022
FIGURE 29 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND)
FIGURE 30 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030)
FIGURE 31 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE
FIGURE 32 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022
FIGURE 33 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND)
FIGURE 34 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030)
FIGURE 35 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE
FIGURE 36 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022
FIGURE 37 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND)
FIGURE 38 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030)
FIGURE 39 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE
FIGURE 40 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022
FIGURE 41 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 42 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030)
FIGURE 43 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE
FIGURE 44 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022
FIGURE 45 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 46 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030)
FIGURE 47 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE
FIGURE 48 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 49 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 50 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 51 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 52 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022)
FIGURE 53 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022)
FIGURE 54 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 55 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 56 NORTH AMERICA TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030)
FIGURE 57 NORTH AMERICA TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%)
